Pandemic preparedness: different perspectives. How ready are we for the next pandemic?

Abstract:

:Europe is not ready for the next pandemic. Nonetheless, several positive developments are cause for optimism. The European Centre for Disease Control (ECDC) was founded in May 2005 and has explicitly identified influenza as one of its top four priorities. Europe is also taking steps to streamline the regulatory approval of new vaccines during a pandemic. Europe can learn much from Canada. The Canadian public health authorities have focused on developing the infrastructure, procedures and acceptance for vaccination against the annual influenza epidemics as a means of strengthening pandemic preparedness. The Canadians are also stockpiling antiviral drugs. These drugs are an excellent way to bridge the gap between the appearance of a pandemic virus and the development of an effective vaccine against it. The World Health Organisation (WHO) is driving change on a global level and will table a pandemic preparedness plan at the next World Health Assembly. Preparing now, during the interpandemic period, is the best way to prepare for a pandemic.

journal_name

Vaccine

journal_title

Vaccine

authors

doi

10.1016/j.vaccine.2006.06.066

subject

Has Abstract

pub_date

2006-11-10 00:00:00

pages

6800-6

issue

44-46

eissn

0264-410X

issn

1873-2518

pii

S0264-410X(06)00812-7

journal_volume

24

pub_type

杂志文章

相关文献

VACCINE文献大全
  • Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres.

    abstract::Oral administration of antigen is known to be appropriate for some vaccine purposes as well as oral tolerance induction. In the present study, oral administration of beta-lactoglobulin (BLG) loaded poly(D,L-lactide-co-glycolide) (D,L-PLG) microspheres induced tolerance was evaluated. A single feeding of 5 micrograms o...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(99)00384-9

    authors: Pecquet S,Leo E,Fritsché R,Pfeifer A,Couvreur P,Fattal E

    更新日期:2000-01-18 00:00:00

  • Leptospiral immunoglobulin-like proteins elicit protective immunity.

    abstract::The identification of new vaccine candidates for leptospirosis is of great interest. This paper describes the identification of two homologous immunogenic proteins, LigA-m and LigB-m, of Leptospira interrogans serovar manilae strain UP-MMC-NIID, which show strong similarity with LigA found recently in L. interrogans s...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2003.10.007

    authors: Koizumi N,Watanabe H

    更新日期:2004-03-29 00:00:00

  • Hospitalised rotavirus gastroenteritis in New Zealand: The laboratory database is a valuable tool for assessing the impact of rotavirus vaccination.

    abstract:AIM:To assess the impact of the introduction of rotavirus vaccination in New Zealand at a regional and national level, underlining the utility of a passively collected laboratory dataset. METHOD:Retrospective laboratory data for rotavirus testing from Wellington and Hutt Hospitals from 1 January 2010 to 31 December 20...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.07.018

    authors: Kelly MJ,Foley D,Blackmore TK

    更新日期:2017-08-16 00:00:00

  • Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

    abstract::Post-licensure real world evaluation of vaccine implementation is important for establishing evidence of vaccine effectiveness (VE) and programme impact, including indirect effects. Large cohort studies offer an important epidemiological approach for evaluating VE, but have inherent methodological challenges. Since Ma...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2015.07.062

    authors: King C,Beard J,Crampin AC,Costello A,Mwansambo C,Cunliffe NA,Heyderman RS,French N,Bar-Zeev N,VacSurv Consortium.

    更新日期:2015-09-11 00:00:00

  • Strategies to prevent and control hepatitis B and C virus infections: a global perspective.

    abstract::Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of acute and chronic liver disease worldwide. Chronic infection with these viruses often leads to chronic liver disease, including cirrhosis or primary hepatocellular carcinoma. Both HBV and HCV are bloodborne viruses; however, HBV is transmitted eff...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/s0264-410x(98)00415-0

    authors: Mast EE,Alter MJ,Margolis HS

    更新日期:1999-03-26 00:00:00

  • Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.

    abstract::Since children with chronic diseases represent a primary target for immunization strategies, it is important that their immunization coverage and timeliness of vaccines is optimal. We performed a study to measure immunization coverage and timeliness of vaccines in children with type 1 diabetes, HIV infection, Down syn...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.02.099

    authors: Pandolfi E,Carloni E,Marino MG,Ciofi degli Atti ML,Gesualdo F,Romano M,Giannattasio A,Guarino A,Carloni R,Borgia P,Volpe E,Perrelli F,Pizzuti R,Tozzi AE

    更新日期:2012-07-20 00:00:00

  • A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

    abstract::Malignant catarrhal fever (MCF) is a fatal lymphoproliferative disease of cattle that, in East Africa, results from transmission of the causative virus, alcelaphine herpesvirus 1 (AlHV-1), from wildebeest. A vaccine field trial involving an attenuated AlHV-1 virus vaccine was performed over two wildebeest calving seas...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2015.12.009

    authors: Lankester F,Russell GC,Lugelo A,Ndabigaye A,Mnyambwa N,Keyyu J,Kazwala R,Grant D,Percival A,Deane D,Haig DM,Cleaveland S

    更新日期:2016-02-03 00:00:00

  • Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.

    abstract::Swine influenza virus (SIV) is not only an important respiratory pathogen in pigs but also a potent threat to human health. Although immunization with recombinant poxviruses expressing protective antigens as vaccines has been widely used for against many infectious diseases, development of recombinant swinepox virus (...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2012.02.028

    authors: Xu J,Huang D,Liu S,Lin H,Zhu H,Liu B,Lu C

    更新日期:2012-04-26 00:00:00

  • Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.

    abstract::Tick-borne encephalitis (TBE) is a potentially serious disease, especially in adults. There is no treatment available for TBE; supportive therapy may help to ease symptoms of the disease. Vaccination is the most effective method of preventing TBE disease and is recommended for those who live, work, or travel in TBE-en...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2008.11.082

    authors: Plentz A,Jilg W,Schwarz TF,Kuhr HB,Zent O

    更新日期:2009-02-05 00:00:00

  • Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.

    abstract::Respiratory syncytial virus (RSV) is a leading viral cause of respiratory morbidity and mortality in infants and young children worldwide. Low and middle income countries (LMICs) account for approximately 99% of the global mortality estimates in this population, with up to 200,000 RSV deaths per year. The vaccine prod...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2017.02.068

    authors: Giersing BK,Karron RA,Vekemans J,Kaslow DC,Moorthy VS

    更新日期:2019-11-28 00:00:00

  • Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults.

    abstract::Ten prospective clinical trials conducted in elderly and high-risk adults have failed to show that pneumococcal vaccine prevents pneumococcal bacteraemia and all pneumonia. Several of these trials focused on unrepresentative populations and most had serious methodological problems. Few adequately considered sample siz...

    journal_title:Vaccine

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.vaccine.2003.09.027

    authors: Fedson DS,Liss C

    更新日期:2004-02-25 00:00:00

  • Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).

    abstract::This study examines the potential clinical and economic benefits for adults arising from paediatric pneumococcal vaccination in the UK. A UK birth cohort model with a 10-year horizon and using a primary 4-dose paediatric 7-valent pneumococcal conjugate vaccine (PCV) schedule was populated with 1999 morbidity and morta...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2004.08.051

    authors: McIntosh ED,Conway P,Willingham J,Hollingsworth R,Lloyd A

    更新日期:2005-02-25 00:00:00

  • Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.

    abstract:BACKGROUND:This randomised, open label, phase I, immunotherapeutic study investigated the effects of interleukin (IL)-2, granulocyte-macrophage colony-stimulating factor (GM-CSF), recombinant human growth hormone (rhGH), and therapeutic immunisation (a Clade B DNA vaccine) on combination antiretroviral therapy (cART)-t...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2014.09.072

    authors: Herasimtschuk A,Downey J,Nelson M,Moyle G,Mandalia S,Sikut R,Adojaan M,Stanescu I,Gotch F,Imami N

    更新日期:2014-12-05 00:00:00

  • Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

    abstract::Since inactivated influenza vaccines mainly confer protective immunity by inducing strain-specific antibodies to the viral hemagglutinin, these vaccines only afford protection against infection with antigenically matching influenza virus strains. Due to the continuous emergence of antigenic drift variants of seasonal ...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2014.11.054

    authors: Altenburg AF,Rimmelzwaan GF,de Vries RD

    更新日期:2015-01-15 00:00:00

  • Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.

    abstract::As measured by fluid accumulation in ileal loops, Vibrio cholerae mucinase complex, with or without toxoid, protected guinea pigs from challenges with V. cholerae live organisms and enterotoxin. The neuraminidase and proteinases of the complex were combined in modified oil emulsion or aluminum hydroxide adjuvants and ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2003.12.004

    authors: Stewart-Tull DE,Lucas C,Bleakley CR

    更新日期:2004-06-02 00:00:00

  • Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.

    abstract::Rotavirus (RV) is the primary etiologic agent of severe gastroenteritis in human infants. Although two attenuated RV-based vaccines have been licensed to be applied worldwide, they are not so effective in low-income countries, and the induced protection mechanisms have not been clearly established. Thus, it is importa...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2015.03.080

    authors: Badillo-Godinez O,Gutierrez-Xicotencatl L,Plett-Torres T,Pedroza-Saavedra A,Gonzalez-Jaimes A,Chihu-Amparan L,Maldonado-Gama M,Espino-Solis G,Bonifaz LC,Esquivel-Guadarrama F

    更新日期:2015-08-20 00:00:00

  • Data management of clinical trials during an outbreak of Ebola virus disease.

    abstract:INTRODUCTION:Clinical trial data management (DM) conducted during outbreaks like that of Ebola virus disease (EVD) in West Africa, 2014-2016, has to adapt to specific, unique circumstances. CTU Bern was asked to set up a safe data capture/management system that could be launched within a few weeks and cover two differe...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.09.094

    authors: Hossmann S,Haynes AG,Spoerri A,Diatta ID,Aboubacar B,Egger M,Rintelen F,Trelle S

    更新日期:2019-11-15 00:00:00

  • Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines.

    abstract::We recently described the use of ion exchange chromatography for analysis and the industrial scale preparation of pools of oligosaccharides of intermediate chain length from polysaccharides of Haemophilus influenzae type b (Hib) and Neisseria meningitidis groups A and C. These negatively charged "sized" oligosaccharid...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(99)00092-4

    authors: Ravenscroft N,Averani G,Bartoloni A,Berti S,Bigio M,Carinci V,Costantino P,D'Ascenzi S,Giannozzi A,Norelli F,Pennatini C,Proietti D,Ceccarini C,Cescutti P

    更新日期:1999-07-16 00:00:00

  • A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.

    abstract:BACKGROUND:This phase I trial evaluated the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost, previously demonstrated to be protective in animal studies, in healthy UK adults. METHODS:We enrolled 42 healthy, BCG-vaccinated adults into 4 groups: low dose Starter ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2019.10.102

    authors: Wilkie M,Satti I,Minhinnick A,Harris S,Riste M,Ramon RL,Sheehan S,Thomas ZM,Wright D,Stockdale L,Hamidi A,O'Shea MK,Dwivedi K,Behrens HM,Davenne T,Morton J,Vermaak S,Lawrie A,Moss P,McShane H

    更新日期:2020-01-22 00:00:00

  • Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.

    abstract::Live, attenuated hepatitis A vaccines are used widely in China but there is uncertainty regarding the persistence of vaccine-induced anti-HAV antibodies after single dose and booster dose administrated at month 12. A large scale clinical trial to evaluate the live, attenuated hepatitis A vaccine was conducted in Hebei...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2006.08.004

    authors: Wang XY,Xu ZY,Ma JC,von Seidlein L,Zhang Y,Hao ZY,Han OP,Zhang YL,Tian MY,Ouyang PY,Zhang ZY,Han CQ,Xing ZC,Chen JC

    更新日期:2007-01-05 00:00:00

  • Immunogenicity of a fusion protein linking the beta subunit carboxyl terminal peptide (CTP) of human chorionic gonadotropin to the B subunit of Escherichia coli heat-labile enterotoxin (LTB).

    abstract::Human chorionic gonadotropin (hCG) is currently under investigation as an antigenic target in both anti-cancer and anti-fertility vaccines. Formulations studied to date show promise in clinical trials for both applications yet are expensive to produce and require frequented administration in order to maintain an effec...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(96)00046-1

    authors: Rock EP,Reich KA,Lyu DM,Hovi M,Hardy J,Schoolnik GK,Stocker BA,Stevens V

    更新日期:1996-11-01 00:00:00

  • IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: a single-blind phase I study.

    abstract::sLAG-3 (IMP321), a natural high affinity ligand for MHC class II, was tested for safety, tolerability and its ability to increase Th-1-type T cell responses to a commercial trivalent split influenza vaccine (Agrippal) in a phase I single-blinded, randomized, controlled clinical trial. Twenty healthy volunteers were fi...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2007.04.019

    authors: Brignone C,Grygar C,Marcu M,Perrin G,Triebel F

    更新日期:2007-06-11 00:00:00

  • Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.

    abstract::Infectious laryngotracheitis virus (ILTV) is an alphaherpesvirus that causes acute respiratory disease in chickens worldwide. The virus is horizontally transmitted and causes large outbreaks of disease. Recent studies have shown that a glycoprotein G deficient candidate vaccine strain of ILTV (ΔgG ILTV) is safe and pr...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.06.002

    authors: Devlin JM,Hartley CA,Gilkerson JR,Coppo MJ,Vaz P,Noormohammadi AH,Wells B,Rubite A,Dhand NK,Browning GF

    更新日期:2011-08-05 00:00:00

  • Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.

    abstract:BACKGROUND:Seasonal influenza infections among young children in China lead to substantial numbers of hospitalizations and financial burden. This study assessed the seasonal influenza vaccine effectiveness (VE) against laboratory confirmed medically attended influenza illness among children in Suzhou, China, from Octob...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2016.03.056

    authors: Wang Y,Zhang T,Chen L,Greene C,Ding Y,Cheng Y,Yang C,Zeng S,Hua J,Zhou S,Song Y,Luan L,Zhang J,Zhao G

    更新日期:2016-05-05 00:00:00

  • Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.

    abstract::We hypothesized that the ability of BCG vaccination to protect against Mycobacterium tuberculosis is less in hosts exposed to chronic helminthes infection compared to unexposed individuals. To test this hypothesis we evaluated the efficacy of BCG vaccination in protecting against M. tuberculosis challenge in Schistoso...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2004.09.038

    authors: Elias D,Akuffo H,Pawlowski A,Haile M,Schön T,Britton S

    更新日期:2005-02-03 00:00:00

  • Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.

    abstract:BACKGROUND:In 2006 a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in the immunisation programme for infants in The Netherlands and replaced by PCV10 in 2011. Limited data exist about the impact of PCV on the aetiology of CAP as a whole. The aim of the present study is to describe the overall changes in...

    journal_title:Vaccine

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.vaccine.2017.06.049

    authors: Vestjens SMT,Wagenvoort GHJ,Grutters JC,Meek B,Aldenkamp AF,Vlaminckx BJM,Bos WJW,Rijkers GT,van de Garde EMW

    更新日期:2017-07-24 00:00:00

  • Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand.

    abstract::Hepatitis B (HB) immunization was introduced as part of the expanded programme on immunization (EPI) in two provinces in Thailand and evaluated over a four year period. Three doses of HB vaccine were offered to 60,980 newborns at birth, 2 and 6 months of age. The overall coverage for complete HB immunization was 90.4%...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(96)00226-5

    authors: Chunsuttiwat S,Biggs BA,Maynard J,Thamapalo S,Laoboripat S,Bovornsin S,Charanasri U,Pinyowiwat W,Kunasol P

    更新日期:1997-04-01 00:00:00

  • Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers.

    abstract:BACKGROUND:Previous reports mostly from Europe suggested an association between an occurrence of narcolepsy and an influenza A(H1N1)pdm09 vaccine adjuvanted with AS03 (Pandemrix(®)). During the 2009 H1N1 pandemic vaccination campaign, the Korean military performed a vaccination campaign with one type of influenza vacci...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2015.07.055

    authors: Kim WJ,Lee SD,Lee E,Namkoong K,Choe KW,Song JY,Cheong HJ,Jeong HW,Heo JY

    更新日期:2015-09-11 00:00:00

  • Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain.

    abstract::Immunization of hairless mice with a TK-, ACVr, non-pathogenic herpes simplex virus (HSV) type 1 mutant protected the mice against reinfection with lethal doses of the parental pathogenic HSV strain. The protection conferred by the mutant against the establishment of latency after reinfection with the parental strain ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(84)90089-6

    authors: Klein RJ,Kaley LA,Friedman-Kien AE

    更新日期:1984-09-01 00:00:00

  • Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

    abstract::An effective virus-like particle (VLP) based prophylactic vaccine designed to protect against persistent infection with human papillomavirus (HPV) types 16 and 18 and subsequent lesion development will need to induce a strong humoral and cellular immune response capable of providing long-term protection. Our objective...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2006.06.005

    authors: Giannini SL,Hanon E,Moris P,Van Mechelen M,Morel S,Dessy F,Fourneau MA,Colau B,Suzich J,Losonksy G,Martin MT,Dubin G,Wettendorff MA

    更新日期:2006-08-14 00:00:00